 Tharindumala Abeywardana
|
|
| School | Vc-health Sciences-schools |
|---|
| Address | 9500 Gilman Drive #
La Jolla CA 92093
|
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. Br J Cancer. 2020 Apr; 122(9):1288-1297.
Dai W, Wang G, Chwa J, Oh ME, Abeywardana T, Yang Y, Wang QA, Jiang L. PMID: 32147668.
View in: PubMed Mentions: 2 Fields:
-
CARM1 suppresses de novo serine synthesis by promoting PKM2 activity. J Biol Chem. 2018 09 28; 293(39):15290-15303.
Abeywardana T, Oh M, Jiang L, Yang Y, Kong M, Song J, Yang Y. PMID: 30131339.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on a-Synuclein Aggregation and Toxicity. ACS Chem Biol. 2016 Apr 15; 11(4):931-42.
Lewis YE, Abeywardana T, Lin YH, Galesic A, Pratt MR. PMID: 26726734.
View in: PubMed Mentions: 3 Fields: Translation: Cells
-
Synthetic Proteins and Peptides for the Direct Interrogation of a-Synuclein Posttranslational Modifications. Biomolecules. 2015 Jun 25; 5(3):1210-27.
Pratt MR, Abeywardana T, Marotta NP. PMID: 26120904.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Extent of inhibition of a-synuclein aggregation in vitro by SUMOylation is conjugation site- and SUMO isoform-selective. Biochemistry. 2015 Feb 03; 54(4):959-61.
Abeywardana T, Pratt MR. PMID: 25607946.
View in: PubMed Mentions: 18 Fields: Translation: Cells
-
Using chemistry to investigate the molecular consequences of protein ubiquitylation. Chembiochem. 2014 Jul 21; 15(11):1547-54.
Abeywardana T, Pratt MR. PMID: 24976261.
View in: PubMed Mentions: 7 Fields: Translation: Cells
-
Site-specific differences in proteasome-dependent degradation of monoubiquitinated a-synuclein. Chem Biol. 2013 Oct 24; 20(10):1207-13.
Abeywardana T, Lin YH, Rott R, Engelender S, Pratt MR. PMID: 24210006.
View in: PubMed Mentions: 13 Fields: Translation: Cells
-
O-GlcNAc modification prevents peptide-dependent acceleration of a-synuclein aggregation. Chembiochem. 2012 Dec 21; 13(18):2665-70.
Marotta NP, Cherwien CA, Abeywardana T, Pratt MR. PMID: 23143740.
View in: PubMed Mentions: 17 Fields: Translation: Cells
-
Semisynthetic, site-specific ubiquitin modification of a-synuclein reveals differential effects on aggregation. J Am Chem Soc. 2012 Mar 28; 134(12):5468-71.
Meier F, Abeywardana T, Dhall A, Marotta NP, Varkey J, Langen R, Chatterjee C, Pratt MR. PMID: 22404520.
View in: PubMed Mentions: 30 Fields: Translation: HumansCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2012 | 2 | | 2013 | 1 | | 2014 | 1 | | 2015 | 2 | | 2016 | 1 | | 2018 | 1 | | 2020 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|